HC Surgical Specialists Gestione

Gestione criteri di controllo 2/4

HC Surgical Specialists Il CEO è Sieu Min Heah, nominato in Sep2015, ha un mandato di 9.17 anni. possiede direttamente 41.6% delle azioni della società, per un valore di SGD 17.28M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.6 anni e 8.2 anni.

Informazioni chiave

Sieu Min Heah

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	9.2yrs
Proprietà del CEO	41.6%
Durata media del management	5.6yrs
Durata media del Consiglio di amministrazione	8.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Sieu Min Heah (60 yo)

9.2yrs

Mandato

Dr. Sieu Min Heah, MB BCh, FRCSEd (General Surgery), FAMS General Surgery, has been Chief Executive Officer and Executive Director of HC Surgical Specialists Limited since September 1, 2015.

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Sieu Min Heah	CEO & Executive Director	9.2yrs	Nessun dato	41.6% SGD 17.3m
Soo Ling Ong	Chief Financial Officer	8.8yrs	Nessun dato	Nessun dato
Josephine Tio Melissa	Chief Operating Officer	2.5yrs	Nessun dato	Nessun dato
Kok Hoong Chia	Medical Director & Executive Director	no data	Nessun dato	22.6% SGD 9.4m
Gary Ng	Head of the Internal Audit	no data	Nessun dato	Nessun dato
Hui Theng Lee	Chief Nursing Officer	1.5yrs	Nessun dato	0.065% SGD 27.0k
Moi Heyang Lin	Joint Company Secretary	no data	Nessun dato	Nessun dato
Pei Chan Tang	Joint Company Secretary	no data	Nessun dato	Nessun dato

5.6yrs

Durata media

60yo

Età media

Gestione esperta: Il team dirigenziale di 1B1 è esperto e expertise (durata media dell'incarico 5.6 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Sieu Min Heah	CEO & Executive Director	9.2yrs	Nessun dato	41.6% SGD 17.3m
Kok Hoong Chia	Medical Director & Executive Director	9.2yrs	Nessun dato	22.6% SGD 9.4m
Seng Soon Ooi	Independent Non-Executive Director	8.2yrs	Nessun dato	Nessun dato
Weng Hoe Chong	Independent Non-Executive Chairman	8.2yrs	Nessun dato	0.11% SGD 45.3k
Chye Lai Lim	Non-Independent Non-Executive Director	8.2yrs	Nessun dato	0.16% SGD 67.5k

8.2yrs

Durata media

60yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 1B1 sono considerati esperti (durata media dell'incarico 8.2 anni).

HC Surgical Specialists Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

HC Surgical Specialists Limited, Annual General Meeting, Sep 30, 2024

Insufficient new directors

Insufficient new directors

HC Surgical Specialists Limited, Annual General Meeting, Sep 26, 2023

Insufficient new directors

Insufficient new directors

Recent updates

Full year 2024 earnings released: EPS: S$0.025 (vs S$0.02 in FY 2023)

HC Surgical Specialists Limited Proposes Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 May 2024, Payable on 25 November 2024

New minor risk - Financial data availability

HC Surgical Specialists Limited, Annual General Meeting, Sep 30, 2024

Insufficient new directors

First half 2024 earnings released: EPS: S$0.023 (vs S$0.014 in 1H 2023)

HC Surgical Specialists Limited Declares Interim Dividend for the Financial Year Ending 31 May 2024, Payable on 13 March 2024

HC Surgical Specialists Limited Declares Interim Dividend, Payable on 13 March 2024

Insufficient new directors

Upcoming dividend of S$0.01 per share at 6.3% yield

HC Surgical Specialists Limited Approves A Final Dividend for the Financial Year Ended 31 May 2023

New minor risk - Shareholder dilution

HC Surgical Specialists Limited Proposes Final Dividend for the Financial Year Ended 31 May 2023

HC Surgical Specialists Limited, Annual General Meeting, Sep 26, 2023

Full year 2023 earnings released: EPS: S$0.019 (vs S$0.043 in FY 2022)

New minor risk - Financial data availability

Insufficient new directors

Insufficient new directors

Upcoming dividend of S$0.01 per share at 4.9% yield

HC Surgical Specialists Limited Announces Interim Dividend for the Financial Year Ending 31 May 2023, Payable on 13 March 2023

First half 2023 earnings released

Insufficient new directors

Insufficient new directors

Upcoming dividend of S$0.012 per share

HC Surgical Specialists Limited Approves Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 May 2022

Now 21% undervalued after recent price drop

HC Surgical Specialists Limited, Annual General Meeting, Sep 27, 2022

Full year 2022 earnings released: EPS: S$0.043 (vs S$0.053 in FY 2021)

HC Surgical Specialists Limited Recommends Final Dividend for the Financial Year Ended May 31, 2022

HC Surgical Specialists Limited Appoints Melissa Josephine Tio @ Melissa Josephine Susantio as Chief Operating Officer, Effective 1 May 2022

Insufficient new directors

HC Surgical Specialists Limited Announces Resignation of Chief Operating Officer, Ouyang Yuxia, Connie, Effective 30 April 2022

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of S$0.023 per share

Upcoming dividend of S$0.023 per share

Full year 2021 earnings released: EPS S$0.053 (vs S$0.027 in FY 2020)

HC Surgical Specialists Limited Announces That the Court of Appeal Dismissed

First half 2021 earnings released: EPS S$0.033

New 90-day high: S$0.42

HC Surgical Specialists Limited (Catalist:1B1) agreed to acquire remaining 30% stake in Julian Ong Endoscopy & Surgery (Pte Ltd).

HC Surgical Specialists Limited (Catalist:1B1) acquired 20% stake in Healthcare Essentials Pte. Ltd. from Lim Chye Lai, Gjan for SGD 0.18 million.

HC Surgical Specialists Provides Cashless and Convenient Healthcare Services to Eligible 1 Customers of Prudential Singapore

New 90-day high: S$0.35

New 90-day high - S$0.34

Full year earnings released - EPS S$0.023

New 90-day low - S$0.29

HC Surgical Specialists Limited completed the acquisition of additional 19% stake in Julian Ong Endoscopy & Surgery (Pte Ltd) from Julian Ong Surgery Pte. Ltd. for $3.8 million.

HC Surgical Specialists Limited (Catalist:1B1) completed the acquisition of additional 19% stake in Julian Ong Endoscopy & Surgery Pte. Ltd from Julian Ong Surgery Pte. Ltd.

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media